117 related articles for article (PubMed ID: 36700826)
1. HSF1 activates the FOXO3a-ΔNp63α-CDK4 axis to promote head and neck squamous cell carcinoma cell proliferation and tumour growth.
Wang Y; Zhu Q; Guo S; Ao J; Zhang W; Fei J; Yu S; Niu M; Zhang Y; Sherman MY; Xiao ZJ; Yi Y
FEBS Lett; 2023 Apr; 597(8):1125-1137. PubMed ID: 36700826
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
3. SATB2 augments ΔNp63α in head and neck squamous cell carcinoma.
Chung J; Lau J; Cheng LS; Grant RI; Robinson F; Ketela T; Reis PP; Roche O; Kamel-Reid S; Moffat J; Ohh M; Perez-Ordonez B; Kaplan DR; Irwin MS
EMBO Rep; 2010 Oct; 11(10):777-83. PubMed ID: 20829881
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
5. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.
Hu L; Liang S; Chen H; Lv T; Wu J; Chen D; Wu M; Sun S; Zhang H; You H; Ji H; Zhang Y; Bergholz J; Xiao ZJ
Proc Natl Acad Sci U S A; 2017 May; 114(20):E3964-E3973. PubMed ID: 28468801
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
[TBL] [Abstract][Full Text] [Related]
7. Phospho-DeltaNp63alpha/NF-Y protein complex transcriptionally regulates DDIT3 expression in squamous cell carcinoma cells upon cisplatin exposure.
Huang Y; Chuang AY; Romano RA; Liégeois NJ; Sinha S; Trink B; Ratovitski E; Sidransky D
Cell Cycle; 2010 Jan; 9(2):328-38. PubMed ID: 20023394
[TBL] [Abstract][Full Text] [Related]
8. ΔNp63α promotes Bortezomib resistance via the CYGB-ROS axis in head and neck squamous cell carcinoma.
Zhou P; Zhang C; Song X; Zhang D; Zhu M; Zheng H
Cell Death Dis; 2022 Apr; 13(4):327. PubMed ID: 35397613
[TBL] [Abstract][Full Text] [Related]
9. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
[TBL] [Abstract][Full Text] [Related]
10. HDAC inhibitors suppress the proliferation, migration and invasiveness of human head and neck squamous cell carcinoma cells via p63‑mediated tight junction molecules and p21‑mediated growth arrest.
Kakiuchi A; Kakuki T; Ohwada K; Kurose M; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Kohno T; Himi T; Takano KI; Kojima T
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649777
[TBL] [Abstract][Full Text] [Related]
11. ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas.
Abraham CG; Ludwig MP; Andrysik Z; Pandey A; Joshi M; Galbraith MD; Sullivan KD; Espinosa JM
Cell Rep; 2018 Sep; 24(12):3224-3236. PubMed ID: 30232004
[TBL] [Abstract][Full Text] [Related]
12. The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth.
King KE; Ponnamperuma RM; Allen C; Lu H; Duggal P; Chen Z; Van Waes C; Weinberg WC
Cancer Res; 2008 Jul; 68(13):5122-31. PubMed ID: 18593911
[TBL] [Abstract][Full Text] [Related]
13. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.
Rocco JW; Leong CO; Kuperwasser N; DeYoung MP; Ellisen LW
Cancer Cell; 2006 Jan; 9(1):45-56. PubMed ID: 16413471
[TBL] [Abstract][Full Text] [Related]
14. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
Li C; Johnson DE
Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.
Moses MA; George AL; Sakakibara N; Mahmood K; Ponnamperuma RM; King KE; Weinberg WC
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340447
[TBL] [Abstract][Full Text] [Related]
16. Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma.
Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Hu WY; Chou SH; Liu CJ; Lo JF
J Pathol; 2009 Nov; 219(3):347-55. PubMed ID: 19681071
[TBL] [Abstract][Full Text] [Related]
17. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
[TBL] [Abstract][Full Text] [Related]
18. Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells.
Guha G; Lu W; Li S; Liang X; Kulesz-Martin MF; Mahmud T; Indra AK; Ganguli-Indra G
PLoS One; 2015; 10(5):e0125322. PubMed ID: 25938491
[TBL] [Abstract][Full Text] [Related]
19. A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.
Radhakrishnan A; Nanjappa V; Raja R; Sathe G; Puttamallesh VN; Jain AP; Pinto SM; Balaji SA; Chavan S; Sahasrabuddhe NA; Mathur PP; Kumar MM; Prasad TS; Santosh V; Sukumar G; Califano JA; Rangarajan A; Sidransky D; Pandey A; Gowda H; Chatterjee A
Sci Rep; 2016 Oct; 6():36132. PubMed ID: 27796319
[TBL] [Abstract][Full Text] [Related]
20. Heat shock factor 1 in cancer-associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinoma.
Wang Q; Zhang YC; Zhu LF; Pan L; Yu M; Shen WL; Li B; Zhang W; Liu LK
Cancer Sci; 2019 May; 110(5):1790-1803. PubMed ID: 30843645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]